The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Also note the change of wording “total projected annual sales value of the prospective sales pipeline for Fruitflow, which is now shared across Provexis and DSM, continues to stand at a substantial multiple of existing annual sales.” hopefully DSM might be fully behind this now !
And on the DSM side of things, the prospective sales pipeline remains at substantial multiples of current income. To me that means there are 1 or 2 major players planning to launch based on platelet aggregation claim. Then we have interest from ‘truly global’ for gut modulation. Can’t imagine anything happening on that for a while due to patent and general slowness.
Simply put, because I believe I will get a good return on my investment.
All else aside, By-Health has invested a substantial amount of cash (“‘tens of millions of funds’ (RMB)”) and effort into getting a Fruitflow health claim approved in China and I have no doubt that once approved they will also be looking to get a return.
Sales from China alone should see us well into profit and who knows what else By-Health might be thinking about? 🤔
As always DYOR, WTFDIK etc.
Gixer you’ve amazing staying power here , why ?
The only good news is that the board are still getting their hard earned( LOL) remuneration.
Nothing ever happens, nothing happens at all
The needle returns to the start of the song
And we all sing along like before
and we'll be pixies tonight and pixies tomorrow
What the hell is going on with this share,it dropping every day
Actually, scrap that. It’s not the same article at all.
It’s been quite wide spread that one, I keep seeing it on different outlets each day.
Interesting post
https://m.facebook.com/story.php?story_fbid=pfbid02Xv97pGtSLpCtt2oHkmkSQJD6Yy9Re73zV1rfhbQ1ZKTGXDeAdZQCs8pUjK6CB2fZl&id=100030902936657
And this one
https://money-123-com-cn.translate.goog/show/b987996.html?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Https://m.163.com/dy/article/IH6IBEOG0552ADWT.html?spss=adap_pc
Ah just seemed odd, thanks for clarification.
it's not changed, it's the 26th, the date shown under "pxs share news" is utter ******, which isn't unusual for alliance news.
Has the date of the AGM changed?
Says its Monday Monday 23rd October on here, but the Provexis website has it as the 26th.
Love your Heart with Dr Hilary.
https://www.healthspan.co.uk/advice/heart-health/
If Provexis has already purchased €550k of stock then that would leave around the same amount at DSM.
"The Company and DSM have been in further negotiations around the inventory transfer throughout the course of 2023, and the parties expect to be able to conclude these further negotiations in the coming months. The amount of stock which the Company will finally elect to purchase from DSM remains uncertain, and it will ultimately depend on (i) the best before dates of this inventory, which remain favourable / long dated in light of recent production runs of new Fruitflow material, (ii) recent stability data which suggests that the best before dates could be further extended, (iii) estimated customer demand in 2023/24 and beyond, (iv) the comparative costs and timing of a potential production run for a new batch of material and (v) the Company's financial resources at that time."
Thing is, If DSM was carrying in excess of €1m of stock surly they thought they would be able to sell it.
With “multiples of current revenue” to be filled and possibly 5 or more products to launch , you would think a large run is needed , I suppose if they produce new stock too early there could be a problem .
Just to clarify, when I say new stock I mean from the manufacturer and not the remaining stock that DSM holds.
Since the year end we should have purchased DSM stock of around £160k as we were contracted to do so.
" The Company has contractually committed to purchase more than €550k of Fruitflow inventory from DSM thus far, of which €348k was delivered and paid for in full in the quarter ended 31 March 2023. The remainder of the inventory which the Company has contractually committed to purchase from DSM is expected to be delivered and paid for in April 2023."
"At 31 March 2023 the Group had cash balances of £379,121"
"Sales in excess of £280k have been made post year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers"
My guess would be that IF is not looking to raise funds until we need a new stock of FF.
BWTFDIK :)
Maybe they just don't need to yet
If I can make it to the AGM this year I have questions about funding 1/Ian why has it taken so long to address the funding issue ? Are you having problems ? 2/ this has been hanging over the heads of loyal shareholders for far too long a simple open offer could have sorted this a year ago why has this not happened .
Is anyone coming to the AGM. Just remember everyone our value is the patents. The more we have the higher the price when we get bought out. Last post for me till news comes as its hard to read the rubbish posted on here. Keep up the great work Gixer. I will/am adding as and when I can especially at these prices